14-day Premium Trial Subscription Try For FreeTry Free
Big news is coming for CEL-SCI, and we don't know which way the stock will move.
The stock price of CEL-SCI Corporation (NYSEAMERICAN: CVM) increased by over 5% during intraday trading. This is why it happened.

Cel-Sci: Multikine To Change Standard Of Care

12:15pm, Monday, 12'th Apr 2021
Full data analysis readout is expected in a few weeks. Multikine will change the Standard of Care if successful.
These big jumps had nothing to do with achievements or business quality.
CVM stock is on the move after Cel-Sci CEO Geert Kersten joined the battle against GME stock short-sellers. Here's what to know.
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation to Present at the 2021 H.C. Wainwright BIOCONNECT Virtual Conference
Data lock has been announced, and top line data is to be expected within a few weeks. Trial duration hints towards longer survival than Standard of Care.
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation to Present at the 13th Annual LD Micro Main Event Conference
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI announces the closing of its $14.65 million bought deal.

CEL-SCI Announces Bought Deal Offering

06:44pm, Tuesday, 08'th Dec 2020
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Announces Bought Deal Offering.

CEL-SCI: Data Locked

03:41pm, Monday, 07'th Dec 2020
Data is Locked. NWBO's Data Lock announcement boosted their Market Cap to nearly $2B.
Neuberger Berman Group LLC bought a new stake in CEL-SCI Co. (NYSEAMERICAN:CVM) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institution
CEL-SCI awarded European patent for LEAPS Vaccine in treatment of Rheumatoid Arthritis.
CEL-SCI Corporation issues letter to shareholders.
CEL-SCI Corporation reports third quarter fiscal 2020 financial results.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE